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ABSTRACT 
Nicotine vaccines are a new prevention and treatment method for smoking addiction. They 
are promoted as a method to cease smoking among those who smoke and possibly prevent 
this behaviour from taking place among those who do not smoke. However, offering these 
vaccines to adults, adolescents, and children will undoubtedly raise an ethical debate among 
policy-makers, health professionals, and the public. This paper discusses the possibility of 
using nicotine vaccines treat and prevent smoking among adults/children/adolescents through 
the lenses of two ethical theories: utilitarianism and deontology (Kantianism). From an 
utilitarian perspective, nicotine vaccines are good for society because they provide the 
greatest benefit for the greatest number of individuals. Authors perceive them as a healthy 
ethical choice to prevent and treat smoking. And, from the deontological perspective, nicotine 
vaccines are justified because individuals can prevent the harm of nicotine addiction by 
choosing vaccines or any other smoking prevention and treatment methods.  
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1. Introduction 
Smoking behaviour is an unhealthy behaviour that increases morbidity rates and adverse 
health outcomes (Hasman & Holm, 2004). Evidence from research demonstrates that 
smoking behaviour causes lung cancer, emphysema, and coronary disease; and, contributes 
significantly to increased mortality rates (Baliunas, Patra, Rehm, Popova, & Taylor, 2007). In 
Canada, lung cancer is the leading cause of cancer death. Smoking behavior caused 85% of 
these deaths. (Canadian Cancer Society’s Advisory Committee on Cancer Statistics, 2017).  
Although Canada has advanced policies to prevent smoking and lower smoking rates 
(Government of Canada, 2012), the latest Canadian statistics indicate that 16.9% of 
Canadians aged 12 and older (about 5.2 million people) smoke every day or occasionally 
(Statistics Canada, 2017). A study conducted in the United States of America (USA) by 
Eaton et al.  (2010) found that 46.3% of people experimented with tobacco when they were 
adolescents. Despite these statistics, mortality and morbidity rates related to smoking 
behaviour in Canada remain high. Clearly, innovative, evidence-based smoking cessation and 
prevention methods are needed to minimize the risk of smoking behaviour in Canada.    
One of the latest innovative methods for treatment and prevention of smoking behaviour is 
the nicotine vaccine. Many researchers are looking forward to investigating nicotine vaccines 
as an immunological therapy to prevent and treat smoking. Nicotine vaccines provide 
protection against tempting pleasures that lead to smoking addiction (Lieber & Millum, 
2013). These vaccines stimulate the production of antibodies that bind to nicotine molecules 
and prevent nicotine from reaching the brain (Cornuz et al., 2008; Goniewicz & Delijewski, 
2013). Some studies even suggest that these vaccines can probably combat smoking addiction 
before it starts by offering it to children by the age of 10 years (Lev, Wilfond, & McBride, 
  
 
2013). Therefore, using these vaccines for adults, adolescents and children will undoubtedly 
raise an ethical debate among policy-makers, health professionals, and the public. In this 
paper, the authors will drive an argumentative ethical analysis using the utilitarianism and 
deontology (Kantianism) ethical philosophies to discuss the ethical implications of using 
these vaccines to prevent and treat smoking behaviour. Specifically, topics discussed are:  
effectiveness of nicotine vaccines, ethical analysis of using nicotine vaccines, and concludes 
with implications for future inquiry.  
2. Effectiveness of Nicotine Vaccines  
Pharmaceutical companies have developed and tested three nicotine vaccines: NicVAX, 
CYT002-NicQb, and TA-NIC (Cornuz et al., 2008; Goniewicz & Delijewski, 2013; Lieber & 
Millum, 2013).  Clinical trials have been carried out to study the effectiveness of these 
vaccines on adults as a smoking cessation tool. They have passed phase I and II testing by 
showing a positive efficacy, identification of side effects, and by determination of appropriate 
dosages (Lieber & Millum, 2013). Experimental studies indicated that after 12 months of 
providing the nicotine vaccines for adult smokers, smoking cessation rates were between 16-
42%, depending on the type and dose of vaccines (Cornuz et al., 2008; Lieber & Millum, 
2013). Also reported is that nicotine vaccines are safe and well tolerated. The most observed 
side effects were a temporary mild pain at the injection site (tenderness swelling, and ache), 
flu-like symptoms, dry mouth, and headache (Cornuz et al., 2008; Goniewicz & Delijewski, 
2013). Conversely, phase III testing demonstrated that some vaccines have cessation rates 
comparable to other smoking cessation methods such as nicotine patches and bupropion. It is 
important to note that the regular smoking cessation methods work on the brain to change the 
nicotine addiction process, while nicotine vaccines target nicotine molecules in the 
bloodstream.  When the body is injected with the nicotine vaccines, plasma cells produce 
nicotine-specific antibodies that circulate in the bloodstream and prepare to bind to nicotine 
molecules. When nicotine enters the body by inhaling smoking, these antibodies bind to 
nicotine molecules and form complex compounds that are too large to cross the blood-brain 
barrier, leading to a lower nicotine action (Goniewicz & Delijewski, 2013). It has been found 
that the nicotine vaccines can reduce nicotine permeability into the brain by up to 65% 
(Leader, Lerman, & Cappella, 2010). Stage III results indicate that nicotine vaccines may not 
wholly prevent nicotine from reaching the brain. Therefore, it has been recommended that the 
combination of vaccine treatments with nicotine replacement therapy products may be 
compatible to treat smoking behaviour (Goniewicz & Delijewski, 2013).  
Many researchers agree that nicotine vaccines are a promising tool for smoking cessation 
(Goniewicz & Delijewski, 2013; Hasman & Holm, 2004) The vaccines have been developed 
as an active immunization treatment that helps smokers quit by ensuring that cessation is 
effective (Hasman & Holm, 2004). Leader, Lerman, and Cappella (2010) declared that 53% 
of adult smokers would likely try the nicotine vaccines to quit smoking when the vaccines are 
available.  These vaccines have the potential to provide an opportunity to prevent nicotine 
addiction among adolescents and children who do not smoke to immunize them against 
potential future smoking behaviour. In this case, the vaccine will prevent smoking in two 
ways. First, adolescents and children will less likely experiment with tobacco. Second, if 
adolescents and children decide to experiment with smoking, nicotine addiction will not 
follow, and it will be easy for them to quit because nicotine will not cross their brain barriers 
(Hasman & Holm, 2004). However, no studies (e.g., longitudinal studies) could be found 
showing the effect of these vaccines on adults, adolescents and children who have never 
smoked tobacco. Reseachers only speculated that using vaccines as a preventative method for 
  
 
smoking behaviour if it is given to adults, adolescents and children who never smoked would 
prevent those poulations from involving themselves in smoking behaviour in the future or 
quit smoking if they currently smoke (Lieber & Millum, 2013). 
Vaccinating adults who smoke with the nicotine vaccines is likely going to be accepted by 
the majority of smokers who are willing to quit. Whereas vaccinating adolescents and 
children to immunize them against smoking behavior will have critical and needed ethical 
scrunity by the parents/legal guardians (Lieber & Millum, 2013). Consequently, ethical 
analysis is required before policy-makers and health professionals make any decisions about 
offering nicotine vaccines for adults, adolescents and children. The ethical inquiry and debate 
will provide researchers with guidance for researchers regarding scientific support for the 
effectiveness and long-term implications (Lev et al., 2013). Ethical analysis of nicotine 
vaccines also provides policy makers, healthcare providers, and the public with ethical 
direction about usefulness and safety of these products. Using nicotine vaccines to prevent 
and treat smoking will be discussed next from two ethical models: utilitarianism and 
deontology (Kantianism).  
3. Ethical Analysis of Using Nicotine Vaccines 
3.1 Utilitarianism Model 
“The doctrine that the basis of morals is utility, or the greatest happiness principle, holds that 
actions are right in proportion as they tend to promote happiness, wrong in proportion as they 
tend to produce the reverse of happiness. By ‘happiness’ is meant pleasure and the absence of 
pain; by ‘unhappiness’ is meant pain and the lack of pleasure (Mill, 1863/2017, p.4 ).” 
Utilitarian ethics is characterized as the ethics of duty where morality of an action policy, or 
program is based on the greatest amount of benefit obtained for the greatest number of 
individuals (Bellefleur & Keeling, 2016; Kahane,  Everett, Earp, Farias, & Savulescu, 2015 ; 
Mandal, Ponnambath, & Parija, 2016). Albeit, utilitarian ethics is a society-centered 
philosophy because the outcomes of utilitarian philosophy provide the greatest benefit 
expected for the society. This philosophy has two approaches; act utilitarianism and rule 
utilitarianism. Act utilitarianism is the process of making decisions for each case by 
analyzing the benefits and harms promoting general better consequences. Rule utilitarianism 
is the process of making decision that is guided by performed rules and based on evidence. 
However, the outcomes of utilitarian approaches may cause harm to some individuals 
because they may conflict with their moral or religious beliefs (Mandal et al., 2016). 
Nicotine vaccines will not only reduce the smoking prevalence, but it has economic impacts, 
environmental impacts, and social impacts (Venkatesh, 2013). However, discussing the 
impact is beyond the scope of this paper.  From a utilitarianism perspective, vaccination 
against smoking behaviour may have the probability of reducing smoking rates in the society 
and reducing the adverse health outcomes of smoking. Although the long-term side effects of 
nicotine vaccines are not studied yet, the current scientific studies suggest that giving these 
vaccines to adults is likely safe with mild temporary side effects that are comparable to any 
other vaccines. Nicotine vaccines also have low cost, which is likely to facilitate their 
widespread distribution for public health purposes in healthcare systems (Goniewicz & 
Delijewski, 2013). Consequently, if public health offers these vaccines for adults as a 
smoking cessation tool, the greatest benefit for the society will be achieved by reducing the 
smoking rate and its adverse outcomes (morbidity and mortality) (Lieber & Millum, 2013). 
  
 
Eaton et al. (2010) indicated that children start experimenting with smoking at the age of 11-
17 years. If we assume that the nicotine vaccine is an effective intervention for children with 
minimum side effects, it will, therefore, reduce the possibility for them to become smokers 
and protect children from being smokers in future. Consequently, the expected harm from 
nicotine vaccines is far lower than the harm of nicotine addiction (Lieber & Millum, 2013). 
From the utilitarian view, vaccinating children against smoking will lead to the greatest 
benefit to the society. Smoking vaccination programs are also going to be highly efficient in 
low socio-economic societies where children are at high risk to become smokers in their lives 
(Goniewicz & Delijewski, 2013). In this case, the greatest benefit for the society can be 
achieved by empowering parents/legal guardians to vaccinate their children against smoking 
as a healthy choice for them. 
A further benefit of nicotine vaccination is that the economic costs of smoking are far more 
significant than nicotine vaccination costs (Goniewicz & Delijewski, 2013). In Canada, 
smoking costs about 16.2 billion per year in direct and indirect costs (Dobrescu, Bhandari, 
Sutherland, & Dinh, 2017). When adult smokers and children with high risks of becoming 
smokers are immunized against smoking, a large number of the community will be protected 
against nicotine addiction and its consequence of harm. A lot of money can be saved and may 
be spent on other beneficial community projects. From utilitarianism’s perspective, the 
nicotine vaccines can be ethical to be provided through public health prevention programs as 
it provides the greatest good for the greatest number of individuals. Therefore, if the 
Canadian public healthcare system adopts a cost-effective nicotine vaccines program, there is 
a possibility that mortality and morbidity rates caused by smoking will be decreased, and as a 
result, health services will be enhanced.  
3.2 Deontology (Kantianism) Model  
In contrast to utilitarian, deontological ethics is defined as "the ethics of duty where the 
morality of an action depends on the nature of the action" (Mandal, Ponnambath, & Parija, 
2016, para. 3). That is, some of human acts are considered wrong and some are considered 
right because their nature is wrong or right and not because they lead to wrong or good 
outcomes (Kant, 2014/1875).  Based on this premise of deontology, deontologists judge 
human acts regardless of their consequences, inclinations, intentions, desires and emotions. 
The human acts are considered “good will” when they are good in and of themselves.  
According to Kant, because the human being is the only creature who can rationalize wrong 
and right actions; human beings must act within the moral law or duty that gives him/her the 
guidance to do “good will”. However, consequences of our acts cannot be totally ignored 
when we assess and perform some acts: they are still relevant to give us a framework for our 
duty.         
The decisions of deontological philosophy are probably suitable for an individual, but not 
suitable for all the population. This means that the deontological ethics are patient-centered or 
individual centered philosophy (Mandal, Ponnambath, & Parija, 2016). Hence, decisions 
based on deontological approaches are not easy to explain because very often, they are 
subjective. Deontology has two types: deontological universalism and deontological 
relativism. In deontological universalism, the rules apply to everyone, under all 
circumstances. In deontological relativism, the rules apply to people under certain 
circumstances, or under certain conditions (Kant, 1875). 
  
 
In the case of nicotine vaccination, deontological ethics would support the individual choice 
to prevent harm by taking the vaccination or using any other smoking prevention methods, 
despite the consequences of the decision. For example, a social survey for nicotine 
vaccination has revealed that 66% of smokers, who had tried five smoking cessation methods 
before, are probably going to use the nicotine vaccines (Leader et al., 2010). This result 
indicates that adult smokers, who are willing to quit smoking, may find nicotine vaccines a 
new healthy option for them to stop the unhealthy behaviour. For more elaboration, adult 
smokers are willing to accept the side effect of nicotine vaccines because the expected harm 
of the nicotine vaccines is less than that of nicotine addiction. From deontological lens, the 
motivations for these smokers to use nicotine vaccines are to reduce the harm of nicotine 
addiction and give up a harmful behaviour. On the other hand, the same survey also revealed 
that 28% of adult smokers are not willing to try the nicotine vaccines (Leader et al., 2010). 
The motivations of these smokers to refuse the nicotine vaccines are that they likely consider 
smoking as a lifestyle choice, can use any other smoking cessation method, or have a 
pleasurable feeling that reduces their stress when they smoke (Hasman & Holm, 2004; Lieber 
& Millum, 2013). From a deontological aspect, adults have the duty to prevent the harm of 
nicotine addiction by taking moral actions that prevent any negative consequences.  
There is an ethical discussion regarding the parents’/legal guardians’ power over their 
children. This argument suggests that parents’/legal guardians’ authority is likely preventing 
children from having freedom regarding their future choices. Since nicotine vaccination is 
irreversible, it does, therefore, limit the children's future option in exploring the social 
functions of smoking (Hasman & Holm, 2004). However, as a society, parents/legal 
guardians are entrusted to prevent and protect their children from being caught in harmful 
behaviours like smoking (Lev et al., 2013). Since nicotine addiction causes preventable 
diseases, parents/legal guardians have the power to decide whether or not to vaccinate their 
children. Let us take the assumption that the nicotine vaccines as an effective and safe 
intervention for children and adolescents, reducing the probability that they become smokers 
in their lifetimes. By applying the concepts of deontology on children immunization against 
smoking, parents/legal guardians immunize their kids against smoking because smoking 
behaviour is a harmful and unacceptable regardless of its consequences. The parents’/legal 
guardians’ decision to immunize their children is appropriate for individual child and it is not 
necessary to make positive outcomes on society (Mandal, Ponnambath, & Parija, 2016). For 
more elaboration, the relationship between parents/legal guardians and their children is a 
deontological one because one of expected roles for parents/legal guardians is to protect their 
children against harmful products or behaviours. When this expected role of parents/legal 
guardians is not appropriately performed, their children will be at higher risk to harmful 
products and behaviours. This result will encourage parents/legal guardians to do the right 
action (e.g., immunize their kids against smoking) to keep their children healthy and safe. It 
is vital to note that nicotine vaccines are not like any other infectious disease vaccines as 
nicotine vaccines are used for behavioural enhancement to prevent nicotine addiction (Lev et 
al., 2013).   
From the deontological perspective, parents/legal guardians can have practical reasons to 
agree or refuse to give nicotine vaccines to their children. At the same time, parents/legal 
guardians have the duty to take moral action to prevent and protect their children from 
harmful products and behaviours. Parents/legal guardians may not agree on vaccinating their 
children against smoking because it may affect the well being of their children (Lev et al., 
2013).  Some other arguments suggest that parents/legal guardians think that vaccination 
might cause harm to their children and put them at risk that is preventable (Lieber & Millum, 
  
 
2013). From a deontological perspective, parents’/legal guardians’ motivation to refuse to 
vaccinate their children is to prevent harm and not undermine the children's rights. On the 
other hand, parents/legal guardians who smoke and tried different smoking cessation methods 
will likely accept vaccinating their children against smoking because they do not want their 
children to fall in the same unhealthy behaviour in the future (Hasman & Holm, 2004). Also, 
children who live in low socio-economic conditions have a higher chance to become tobacco 
smokers (Bethell, Simpson, Stumbo, Carle, & Gombojav, 2010).  Therefore, parents/legal 
guardians who live in low socio-economic conditions may also find vaccinating their children 
against smoking is an effective method to prevent their children from being involved in 
current or future smoking behaviour. In conclusion, from the deontological view, 
parents’/legal guardians’ motivation to vaccinate their children is only to prevent the harm of 
nicotine addiction, but they do not take in consideration other consequences of their decision.    
4. Comparison of Utilitarianism and Deontology Perspectives 
The utilitarian and deontological approaches to the nicotine vaccines have essential ethical 
views on providing vaccines against smoking for adults, adolescents, and children. For 
example, utilitarianism argues that giving nicotine vaccines to adult smokers and children 
will lead to the greatest benefit to the society by decreasing smoking rates and its adverse 
health outcomes. On the other hand, deontology (Kantianism) ethics argues that it is an 
individual responsibility to make a moral judgment about taking or refusing the vaccines to 
prevent harm.  Both deontology and utilitarianism support the nicotine vaccines from their 
perspectives. Through the deontological lens, adult smokers can make their choice to accept 
the nicotine vaccines with its temporary side effects, or refuse nicotine vaccination and use 
other smoking cessation methods. Through the deontological lens, parents/legal guardians 
have the choice to accept to vaccinate their children, if they ensure it is safe, efficient, and 
will prevent their children from becoming smokers in the future. They also have the choice to 
refuse to vaccinate their children to avoid harmful side effects, threats to well-being, and 
violation of their children’s autonomy.  
5. Implications for Future Inquiry 
The most critical issue about nicotine vaccines is their health effectiveness and safety on 
adult smokers, adolescents, and children. In this case, future research and random control 
trials are needed to investigate the effectiveness of nicotine vaccines on adolescents and 
children in preventing nicotine addiction in future. Cost-effectiveness analysis is also 
required to decide whether the implementation of the nicotine vaccines in public health is 
affordable.  The social acceptance of nicotine vaccines also needs to be assessed in the 
society.  
6. Conclusion 
Active nicotine vaccines as a new smoking treatment and prevention method will provide 
opportunities for adult smokers to quit nicotine addiction or prevent them from involving in 
this harmful behaviour. Nicotine vaccines also have the potential to provide an opportunity to 
prevent nicotine addiction among children and young adults who do not smoke from being 
smokers in the current time or in the future. However, vaccinating children and adolescents 
against smoking will encumber a tremendous ethical debate among policy-makers, health 
professionals, and the public. The authors of this paper discussed the offering of nicotine 
vaccination for adults, children, and adolescents from utilitarian and deontological ethical 
  
 
models. It is evident that preventing harm and acting toward individuals’ best interest are 
common across the two ethical perspectives. From utilitarian perspective, nicotine 
vaccination is good for the society as it provides the greatest benefit for the greatest number 
of individuals as a healthy choice to prevent smoking among adult and children. However, 
the deontological perspective of nicotine vaccines is more acceptable because an individual 
has the duty to prevent the harm of nicotine addiction by choosing nicotine vaccines or any 
other smoking cessation methods. Parents/legal guardians have the duty also to protect their 
children from the harm of nicotine addiction by making reasonable moral judgments that 
prevent any negative consequences.  The ethical analysis provides researchers with guidance 
to improve research outcomes. Future studies need to be conducted to study the effectiveness 
of nicotine vaccines in preventing nicotine addiction among adolescents and children.  
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